{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:16:13Z","timestamp":1761128173024},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1007\/s10067-004-1032-2","type":"journal-article","created":{"date-parts":[[2004,11,30]],"date-time":"2004-11-30T07:57:04Z","timestamp":1101801424000},"page":"319-323","source":"Crossref","is-referenced-by-count":7,"title":["Cyclophosphamide is contraindicated in patients with a history of transitional cell carcinoma"],"prefix":"10.1007","volume":"24","author":[{"given":"Bjoern G.","family":"Volkmer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyn M.","family":"Seidl-Schlick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dietmar","family":"Bach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imre","family":"Romics","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Kleinschmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,12,1]]},"reference":[{"key":"1032_CR1","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0094-0143(21)00763-1","volume":"11","author":"AS Morrison","year":"1984","unstructured":"Morrison AS (1984) Advances in the etiology of urothelial cancer. Urol Clin North Am 11:557\u2013569","journal-title":"Urol Clin North Am"},{"key":"1032_CR2","first-page":"871","volume":"319","author":"JC O\u2019Keane","year":"1988","unstructured":"O\u2019Keane JC (1988) Carcinoma of the urinary bladder after treatment with cyclophosphamide. N Engl J Med 319:871","journal-title":"N Engl J Med"},{"key":"1032_CR3","first-page":"51","volume":"2","author":"HD Adolphs","year":"1986","unstructured":"Adolphs HD, Bastian HP (1986) Chemoimmunprophylaxe beim oberfl\u00e4chlichen Harnblasenkarzinom. Urologe A 2:51\u201354","journal-title":"Urologe A"},{"key":"1032_CR4","first-page":"276","volume-title":"Pharmacologic principles of cancer treatment","author":"M Colvin","year":"1982","unstructured":"Colvin M (1982) The alkylating agents. In: Chabner BA (ed) Pharmacologic principles of cancer treatment. Saunders, Philadelphia, pp 276\u2013308"},{"key":"1032_CR5","first-page":"467","volume-title":"Kompendium Internistische Onkologie","author":"H Sauer","year":"1996","unstructured":"Sauer H (1996) Substanzprofile: Zytostatika, Hormone, Zytokine. In: Schmoll HJ, H\u00f6ffken K, Possinger K (eds) Kompendium Internistische Onkologie. Springer, Berlin Heidelberg New York, pp 467\u2013471"},{"key":"1032_CR6","doi-asserted-by":"crossref","first-page":"477","DOI":"10.7326\/0003-4819-124-5-199603010-00003","volume":"124","author":"C Talar-Williams","year":"1996","unstructured":"Talar-Williams C, Hijazi YM, Walther MM, Linehan WM, Hallahan CW, Lubensky I (1996) Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis. Ann Intern Med 124:477\u2013484","journal-title":"Ann Intern Med"},{"key":"1032_CR7","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1136\/bmj.3.5767.182-a","volume":"3","author":"PHL Worth","year":"1971","unstructured":"Worth PHL (1971) Cyclophosphamide and the bladder. Br Med J 3:182","journal-title":"Br Med J"},{"key":"1032_CR8","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1056\/NEJM198804213181604","volume":"318","author":"J Pedersen-Bjeergard","year":"1988","unstructured":"Pedersen-Bjeergard J, Ersboll J, Hansen VL (1988) Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin\u2019s lymphoma. N Engl J Med 318:1028\u20131032","journal-title":"N Engl J Med"},{"key":"1032_CR9","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0090-4295(78)90154-1","volume":"11","author":"MS Pearson","year":"1978","unstructured":"Pearson RM, Soloway MS (1978) Does cyclophosphamide induce bladder cancer? Urology 11:437\u2013447","journal-title":"Urology"},{"key":"1032_CR10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000282511","volume":"51","author":"J Kawamura","year":"1993","unstructured":"Kawamura J, Sakurai M, Tsukamoto K, Tochigi H (1993) Leiomyosarcoma of the bladder eighteen years after cyclophosphamide therapy for retinoblastoma. Urol Int 51:49\u201353","journal-title":"Urol Int"},{"key":"1032_CR11","first-page":"247","volume":"106","author":"CN Carney","year":"1982","unstructured":"Carney CN, Stevens PS, Fried FA, Mandell J (1982) Fibroblastic tumor of the urinary bladder after cyclophosphamide therapy. Arch Pathol Lab Med 106:247\u2013249","journal-title":"Arch Pathol Lab Med"},{"key":"1032_CR12","first-page":"1705","volume":"26","author":"P Asten","year":"1999","unstructured":"Asten P, Barrett J, Symmons D (1999) Risk of developing certain malignancies is related to duration of immunosuppressive drug exposure in patients with rheumatic diseases. J Rheumatol 26:1705\u20131714","journal-title":"J Rheumatol"},{"key":"1032_CR13","first-page":"1144","volume-title":"Kompendium Internistische Onkologie","author":"T Czerny","year":"1996","unstructured":"Czerny T (1996) Begleittherapie bei Ifosfamid und Cyclophosphamid. In: Schmoll HJ, H\u00f6ffken K, Possinger K (eds) Kompendium Internistische Onkologie. Springer, Berlin Heidelberg New York, pp 1144\u20131147"},{"key":"1032_CR14","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0022-5347(17)55061-2","volume":"125","author":"GW Chodak","year":"1981","unstructured":"Chodak GW, Straus FW, Schoenberg HW (1981) Simultaneous occurrence of transitional, squamous, and adenocarcinoma of the bladder after 15\u00a0years of cyclophosphamide ingestion. J Urol 125:424\u2013426","journal-title":"J Urol"},{"key":"1032_CR15","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1002\/art.1780380815","volume":"38","author":"CD Radis","year":"1995","unstructured":"Radis CD, Kahl LE, Baker GL, Wasko MC, Cash JM, Gallatin A (1995) Effects of cyclophosphamide on the development of malignancy and on long-term survival of patients with rheumatoid arthritis. A 20-year follow up study. Arthritis Rheum 38:1120\u20131127","journal-title":"Arthritis Rheum"},{"key":"1032_CR16","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0022-5347(17)41912-4","volume":"140","author":"TM Tuttle","year":"1988","unstructured":"Tuttle TM, Williams GM, Marshall FF (1988) Evidence for cyclophosphamide-induced transitional cell carcinoma in a renal transplant patient. J Urol 140:1009\u20131011","journal-title":"J Urol"},{"key":"1032_CR17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0022-5347(17)51902-3","volume":"129","author":"HD Adolphs","year":"1983","unstructured":"Adolphs HD, Bastian HP (1983) Chemoimmune prophylaxis of superficial bladder cancer. J Urol 129:29\u201332","journal-title":"J Urol"},{"key":"1032_CR18","first-page":"2918","volume":"37","author":"MS Soloway","year":"1977","unstructured":"Soloway MS (1977) Intravesical and systemic chemotherapy of murine bladder cancer. Cancer Res 37:2918\u20132929","journal-title":"Cancer Res"},{"key":"1032_CR19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0090-4295(80)90068-0","volume":"16","author":"C Durkee","year":"1980","unstructured":"Durkee C, Benson R (1980) Bladder cancer following administration of cyclophosphamide. Urology 16:145\u2013148","journal-title":"Urology"},{"key":"1032_CR20","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1016\/S0022-5347(01)65395-3","volume":"156","author":"ET Fernandes","year":"1996","unstructured":"Fernandes ET, Manivel JC, Reddy PK, Ercole CK (1996) Cyclophosphamide associated bladder cancer\u2014a highly aggressive disease: analysis of 12 cases. J Urol 156:1931\u20131933","journal-title":"J Urol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-004-1032-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-004-1032-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-004-1032-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T02:11:45Z","timestamp":1625019105000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-004-1032-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12,1]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["1032"],"URL":"https:\/\/doi.org\/10.1007\/s10067-004-1032-2","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12,1]]}}}